Riot Blockchain (NASDAQ:RIOT) and Intellia Therapeutics (NASDAQ:NTLA) are both mid-cap business services companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, analyst recommendations, risk, earnings and dividends.
Valuation and Earnings
This table compares Riot Blockchain and Intellia Therapeutics' revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
---|
Riot Blockchain | $6.84 million | 397.87 | $-20,040,000.00 | ($0.73) | -55.21 |
Intellia Therapeutics | $43.10 million | 81.41 | $-99,530,000.00 | ($2.11) | -24.55 |
Riot Blockchain has higher earnings, but lower revenue than Intellia Therapeutics. Riot Blockchain is trading at a lower price-to-earnings ratio than Intellia Therapeutics, indicating that it is currently the more affordable of the two stocks.
Volatility & Risk
Riot Blockchain has a beta of 4.56, meaning that its share price is 356% more volatile than the S&P 500. Comparatively, Intellia Therapeutics has a beta of 2.09, meaning that its share price is 109% more volatile than the S&P 500.
Analyst Recommendations
This is a summary of recent ratings and recommmendations for Riot Blockchain and Intellia Therapeutics, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
---|
Riot Blockchain | 0 | 0 | 1 | 0 | 3.00 |
Intellia Therapeutics | 0 | 5 | 10 | 0 | 2.67 |
Riot Blockchain currently has a consensus price target of $28.00, indicating a potential downside of 30.52%. Intellia Therapeutics has a consensus price target of $56.6154, indicating a potential upside of 9.28%. Given Intellia Therapeutics' higher probable upside, analysts clearly believe Intellia Therapeutics is more favorable than Riot Blockchain.
Profitability
This table compares Riot Blockchain and Intellia Therapeutics' net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets |
---|
Riot Blockchain | -250.06% | -51.38% | -47.50% |
Intellia Therapeutics | -193.01% | -40.14% | -30.11% |
Institutional and Insider Ownership
9.0% of Riot Blockchain shares are owned by institutional investors. Comparatively, 95.6% of Intellia Therapeutics shares are owned by institutional investors. 3.5% of Riot Blockchain shares are owned by insiders. Comparatively, 4.1% of Intellia Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Summary
Intellia Therapeutics beats Riot Blockchain on 9 of the 14 factors compared between the two stocks.